Aviso Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$919K Sell
32,740
-1,364
-4% -$36.3K 0.41% 53
2025
Q4
$849K Sell
34,104
-4,211
-11% -$106K 0.36% 65
2025
Q3
$976K Sell
38,315
-4,369
-10% -$108K 0.43% 58
2025
Q2
$1.03M Sell
42,684
-7,585
-15% -$177K 0.48% 54
2025
Q1
$1.27M Sell
50,269
-24,757
-33% -$648K 0.68% 43
2024
Q4
$1.99M Sell
75,026
-7,737
-9% -$210K 1.02% 20
2024
Q3
$2.4M Buy
82,763
+1,915
+2% +$55.9K 1.3% 11
2024
Q2
$2.26M Buy
80,848
+573
+0.7% +$15.8K 1.34% 13
2024
Q1
$2.23M Buy
80,275
+34,115
+74% +$947K 1.4% 14
2023
Q4
$1.33M Buy
+46,160
New +$1.4M 0.96% 24

Other funds holding PFE

Aviso Wealth Management's PFE Position: Q1 2026 in Review

Aviso Wealth Management reduced its Pfizer (PFE) stake by 4% in Q1 2026, selling an estimated $36.3K and leaving 32,740 shares worth $919K. The position accounts for 0.41% of the portfolio, ranked #53.

Aviso Wealth Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.4M in Q3 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Aviso Wealth Management held 32,740 shares of Pfizer worth $919K as of Q1 2026.
  • Aviso Wealth Management sold 1,364 Pfizer shares in Q1 2026, an estimated $36.3K.
  • Pfizer made up 0.41% of Aviso Wealth Management's portfolio in Q1 2026, its #53 holding.
  • Aviso Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Aviso Wealth Management's Pfizer position peaked at $2.4M in Q3 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Aviso Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.